Prostaglandin Receptor
Prostaglandin receptor, a sub-family of cell surface seven-transmembrane receptors, are the G-protein-coupled receptors. There are currently ten known prostaglandin receptors on various cell types. Prostaglandins bind to a subfamily of cell surface seven-transmembrane receptors, G-protein-coupled receptors. These receptors are named: DP1-2-DP1, DP2 receptors, EP1-4-EP1, EP2, EP3, EP4 receptors, FP-FP, IP1-2-IP1, IP2 receptors, TP-TP receptor. The prostaglandins are a group of hormone-like lipid compounds that are derived enzymatically from fatty acids and have important functions in the animalbody. There are currently ten known prostaglandin receptors on various cell types.
Prostaglandin Receptor Isoform Specific Products
All Product Categories
-
Prostaglandin Receptor Inhibitors
(169)
View all products
-
Prostaglandin Receptor Agonists
(194)
View all products
-
Prostaglandin Receptor Antagonists
(178)
View all products
-
Prostaglandin Receptor Activators
(25)
View all products
-
Prostaglandin Receptor Modulators
(4)
View all products
-
Prostaglandin Receptor Inducers
(2)
View all products
-
Prostaglandin Receptor Degrader
(1)
View all products
-
Prostaglandin Receptor Controls
(49)
View all products
-
Prostaglandin Receptor Ligands
(3)
View all products
-
Prostaglandin Receptor Related Products (766)
Related Products (766)
-
Antibodies (2)
-
Prostaglandin Receptor Isoform Comparison
-
BGC-20-1531
0 ImagesCat. No.: HY-W394717CAS No.: 1186532-61-5Synonyms: PGN 1531BGC-20-1531 (PGN 1531), a benzenesulfonamide derivative, is a selective EP4 antagonist. BGC-20-1531 binds to PGE2 enhancing the ATPase activity, which are coupled to Gs proteins and thus activate adenylate cyclase generating cAMP and activating PKA. BGC-20-1531 is promising for research of liver disorders.
-
KW-8232 (Standard)
0 ImagesCat. No.: HY-100304ARCAS No.: 217813-15-5KW-8232 (Standard) is the analytical standard of KW-8232 (HY-100304A). This product is intended for research and analytical applications. KW-8232, an orally active anti-osteoporotic agent, and can reduces the biosynthesis of PGE2.
-
Latanoprost tris(triethylsilyl) ether
0 ImagesCat. No.: HY-W701877CAS No.: 477884-78-9Latanoprost tris(triethylsilyl) ether is a precursor in the synthesis of the prostaglandin F2α (PGF2α) receptor (FP receptor) agonist Latanoprost (HY-B0577).
-
ZK118182 Isopropyl ester
0 ImagesCat. No.: HY-125383CAS No.: 154927-31-8ZK118182 Isopropyl ester is the isopropyl ester analog of ZK118182, a prostaglandin analog.
-
EIPA hydrochloride (Standard)
0 ImagesSynonyms: L593754 hydrochloride (Standard); MH 12-43 hydrochloride (Standard); Ethylisopropylamiloride hydrochloride (Standard)EIPA (hydrochloride) (Standard) is the analytical standard of EIPA (hydrochloride). This product is intended for research and analytical applications. EIPA (L593754) hydrochloride is an orally active TRPP3 channel inhibitor with an IC50 of 10.5 μM. EIPA hydrochloride also enhances autophagy by inhibiting Na+/H+-exchanger 3 (NHE3). EIPA hydrochloride inhibits macropinocytosis as well. EIPA hydrochloride can be used in the research of inflammation and cancers, such as gastric cancer, colon carcinoma, pancreatic carcinoma.
-
Enprostil
0 ImagesCat. No.: HY-106550CAS No.: 73121-56-9Synonyms: RS 84135Enprostil (RS 84135) is a prostaglandin E2 derivative. Enprostil can inhibit amogastrin-stimulated gastric acid secretion, as well as reducing the secretion of pepsin. Enprostil can also serve as an antiulcer agent, used for research of duodenal or gastric ulcers.
-
Prostaglandin E1 isopropyl ester
0 ImagesCat. No.: HY-138206CAS No.: 217182-28-0Synonyms: PGE1 isopropyl esterProstaglandin E1 isopropyl ester is an isopropyl ester form of prostaglandin E1 (HY-B0131). Prostaglandin E1 isopropyl ester exhibits a faster penetration flux than prostaglandin E1.
-
Latanoprostene bunod (Standard)
0 ImagesCat. No.: HY-19518RCAS No.: 860005-21-6Synonyms: NCX116 (Standard); LBN (Standard)Latanoprostene bunod (NCX116; LBN) (Standard) is the analytical standard of Latanoprostene bunod. This product is intended for research and analytical applications. Latanoprostene bunod is a nitric oxide-releasing prostaglandin F2α analog. Latanoprostene bunod is a prodrug that, upon instillation into the eye, is hydrolyzed by corneal esterases into two active metabolites: Latanoprost (HY-B0577) and NO. Latanoprost activates the prostaglandin FP receptor to increase the outflow of aqueous humor through the uveoscleral pathway. NO increases aqueous humor drainage through the trabecular meshwork pathway, achieving synergistic enhancement targeting the dual pathways of aqueous humor outflow. Latanoprostene bunod can be used in research related to open-angle glaucoma and ocular hypertension.
-
Ro 23-3423
0 ImagesCat. No.: HY-118765CAS No.: 110996-51-5Ro 23-3423 is a thromboxane synthase inhibitor with an IC50 value of 0.33 μM for human platelet microsomal thromboxane synthase. Ro 23-3423 increases plasma levels of PGF and PGE2 in a dose-dependent manner, accompanied by a decrease in mean systemic arterial pressure and systemic vascular resistance. Ro 23-3423 can be used in the study of general anesthesia.
-
OKY-1581
0 ImagesCat. No.: HY-183483CAS No.: 75987-18-7OKY-1581 is a potent, orally active and selective thromboxane A2 synthase inhibitor. OKY-1581 inhibits TXA2 synthesis and reduces the generation of its stable metabolite TXB2. OKY-1581 shifts arachidonic acid (MCE HY-109590) metabolism toward the production of prostaglandin E, prostaglandin F and 6-keto-prostaglandin F1α. OKY-1581 modulates the TXA2 / PGI2-related eicosanoid balance and inhibits arachidonic acid-induced platelet aggregation without directly inhibiting the cyclooxygenase step. At high oral doses, OKY-1581 also enhances hepatic peroxisomal β-oxidation and reduces serum triglyceride and cholesterol levels. OKY-1581 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage by reducing TXA2-related vasoconstrictive signaling. OKY-1581 can be used in studies of atherosclerosis, cerebral vasospasm after subarachnoid hemorrhage and cardiovascular diseases.
-
Zoliprofen
0 ImagesCat. No.: HY-19646CAS No.: 56355-17-0Synonyms: 480156-SZoliprofen (480156-S), a new non-steroidal anti-inflammatory agent, has potent pain suppressing effect. Zoliprofen has strong antagonistic action against bradykinin, markedly inhibiting all bradykinin-induced edema and pain reactions. Zoliprofen weakly inhibits Arachidonic acid (HY-109590)-induced edema and pain reactions but also inhibits PGE2 synthesis of bovine vesicular gland microsomes.
-
20-Hydroxy-PGF2α
0 ImagesCat. No.: HY-137547CAS No.: 57930-92-420-hydroxy Prostaglandin F2α (20-hydroxy PGF2α) is the ω-oxidation product of PGF2α. Cultured type II alveolar cells from pregnant rabbits metabolize exogenous PGF2α via microsomal cytochrome P450 ω-oxidation, producing 20-hydroxy PGF2α and its 15-hydroxy PGDH metabolites. Cells from male rabbits exhibit only the 15-hydroxy PGDH pathway.
-
BAY-1316957 (Standard)
0 ImagesCat. No.: HY-111539RCAS No.: 1613264-40-6BAY-1316957 (Standard) is the analytical standard of BAY-1316957 (HY-111539). This product is intended for research and analytical applications. BAY-1316957 is a potent, selective and orally active prostaglandin E2 receptor subtype 4 (EP4-R) antagonist with an IC50 of 15.3 nM for human EP4-R. BAY-1316957 has excellent agent metabolism and pharmacoKinetics properties, and can be used for endometriosis research.
-
U-46619 Glycine methyl ester
0 ImagesCat. No.: HY-176074U-46619 Glycine methyl ester has a modification at the C-1 position of U-46619, which uniquely alter its binding properties to the TP receptor or any of the PGH2-metabolizing enzymes. U-46619 is a stable analog of the endoperoxide PGH2. U-46619 is also an agonist of TP receptor. U-46619 can change the shape of platelet, aggregation and contraction of vascular smooth muscle. U-46619 Glycine methyl ester can be studied in research to explore the inhibition of various enzymes in the arachidonic acid metabolic pathway. U-46619 Glycine methyl ester can also act as a lipophilic prodrug form of U-46619 that alters its distribution and pharmacokinetic properties.
-
5-trans-PGE2 (Standard)
0 ImagesCat. No.: HY-135023RCAS No.: 36150-00-2Synonyms: 5-trans Prostaglandin E2 (Standard)5-trans-PGE2 (Standard) is the analytical standard of 5-trans-PGE2. This product is intended for research and analytical applications. 5-trans-PGE2 (5-trans Prostaglandin E2) is the active isomer of PGE2 and a potent activator of aromatase. Supplements the process of paracrine signaling between epithelial cells (expressing high levels of PGE2) and surrounding stromal cells (expressing high levels of aromatase). This process is involved in the growth and development of breast cancer.
-
Travoprost-d7
0 ImagesCat. No.: HY-B0584S2Synonyms: Fluprostenol isopropyl ester-7; AL6221-7; Flu-Ipr-7Travoprost-d7 (Fluprostenol isopropyl ester-d7) is deuterium labeled Travoprost. Travoprost (Fluprostenol isopropyl ester), an isopropyl ester proagent, is a high affinity, selective FP prostaglandin full receptor agonist. Travoprost has the ocular hypotensive efficacy and has the potential for glaucoma and ocular hypertension.
-
Palupiprant (Standard)
0 ImagesCat. No.: HY-103088RCAS No.: 1369489-71-3Synonyms: E7046 (Standard)Palupiprant (Standard) is the analytical standard of Palupiprant (HY-103088). This product is intended for research and analytical applications. Palupiprant (E7046) is an orally bioavailable and specific EP4 antagonist, with IC50 of 13.5 nM and Ki of 23.14 nM. Palupiprant exhibits anti-tumor activities.
-
Aganepag ethanediol
0 ImagesCat. No.: HY-118215CAS No.: 1192760-33-0Synonyms: AGN212409Aganepag ethanediol (AGN212409) is an EP2 (Prostaglandin Receptor) receptor agonist. Aganepag ethanediol may be used in anti-glaucoma research.
-
Litebamine
0 ImagesCat. No.: HY-118760CAS No.: 137031-56-2Litebamine is a phenanthrene alkaloid with antiplatelet activity. Litebamine potently targets arachidonic acid- and collagen-induced platelet aggregation, but shows no activity against thrombin-induced aggregation. Litebamine inhibits arachidonic acid- and collagen-induced ATP release and thromboxane B2 production in rabbit platelets, without altering cyclic AMP levels or phosphoinositide breakdown in rabbit platelets. Litebamine has no effect on platelet-activating factor- or U46619 (HY-108566)-induced aggregation, nor does it affect [3H] inositol monophosphate production in rabbit platelets induced by collagen, platelet-activating factor or thrombin.
-
Terutroban (Standard)
0 ImagesCat. No.: HY-16991RCAS No.: 165538-40-9Synonyms: S-18886 (Standard)Terutroban (Standard) is the analytical standard of Terutroban. This product is intended for research and analytical applications. Terutroban (S-18886) is a selective and orally active thromboxane-prostaglandin (TP) receptor antagonist with an IC500 of 16.4 nM. Terutroban inhibits TXA2 and prostaglandin endoperoxide receptors. Terutroban is a potent antithrombotic agent and possesses antiatherosclerotic and antivasoconstrictor properties.
